...
首页> 外文期刊>Journal of Zhejiang University. Science, A >Intrathymic inoculation of donor liver specific antigen alleviates rejection of liver allotransplantation
【24h】

Intrathymic inoculation of donor liver specific antigen alleviates rejection of liver allotransplantation

机译:静脉内接种供体肝脏特异性抗原可缓解肝同种异体的排斥反应

获取原文
           

摘要

Use and effects of liver specific antigen in orthotopic b%5D=abstract&ck%5b%5D=keyword'>b>liver transplantations were researched in this study. Group I:syngeneic control (Wistar-to-Wistar); Group II:acute rejection (SD-to-Wistar); Group III: Thymic inoculation of SD rat LSA day 7 before transplantation. The observation of common situation and survival time, rejection grades, b%5D=abstract&ck%5b%5D=keyword'>b>NF-кb activity of splenocytes and IL-2mRNA expression of grafted liver were used to analyze acute rejection severity and immune state of animals in different groups. The common situation of group I was very well after transplantation and no signs of rejection were found. Recipients of group II lost body weight progressively. All dead within day 9 to day 13 posttransplantation; median survival time was 10.7±0.51 days. It was an optimal acute rejection control. As for group III, 5 out of 6 recipients survived for a long time and common situation was remarkably better than that of group II. Its rejection grades were significantly lower than that of group II(Pb>NF-кb activity was only detected in group I at day 5 and day 7 after transplantation, whereas high activity of b%5D=abstract&ck%5b%5D=keyword'>b>NF-кb was detected at all time points in groupII and the low b%5D=abstract&ck%5b%5D=keyword'>b>NF-кb activity detected in group III was significantly lower than that of group II (Pb>liver transplantation. We report here for the first time that intrathymic inoculation of LSA can alleviate the rejection of liver allotransplantation; and that grafts can survive for a long time thereby, thus leading to a novel way to achieve b%5D=abstract&ck%5b%5D=keyword'>b>liver transplantation b%5D=abstract&ck%5b%5D=keyword'>b>immunotolerance.
机译:在本研究中研究了肝脏特异性抗原在原位B%=摘要和CK%5B%5d =关键词“> B>肝移植的使用和效应。 I族:同工控制(Wistar-to-Wistar);第II组:急性排斥(SD-to-Wistar);第三组:在移植前的SD大鼠LSA第7天的胸腺接种。观察常见情况和生存时间,抑制等级,B%5D =摘要&CK%5B%5d =关键词'B> B> NF-кB活性接枝肝脏的IL-2mRNA表达的活性分析急性排斥性严重程度和免疫不同群体中的动物状态。群体的常见情况在移植后非常好,没有发现拒绝迹象。第II族的接受者逐渐失去了体重。所有死者在第9天到第13天后持续化;中位生存时间为10.7±0.51天。这是一个最佳的急性排斥控制。至于III族,6名受托人中的5个幸存了很长一段时间,并且常见的情况显着比II组的更好。其排斥率明显低于II族(PB> NF-кB活性,仅在移植后第5天和第7天在第5天中检测到,而B%5D的高活性=摘要&CK%5B%5d =关键字'> B> NF-кB在GroupII的所有时间点检测到,在III组中检测到的低B%5D =摘要和CK%5B%5d =关键词'B> B> B> NF-кB活性显着低于II组(PB>)肝移植。我们首次报告了LSA的Intrathymic接种可以缓解肝同性化的抑制;并且移植物可以从此生存很长时间,从而导致实现B%5D的新方法=摘要&CK%5B% 5d =关键词'> b>肝移植b%5d =摘要&ck%5b%5d =关键词'> b>免疫监督。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号